We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.09B
AUM Growth
-$257M
Cap. Flow
-$296M
Cap. Flow %
-3.26%
Top 10 Hldgs %
15.99%
Holding
2,485
New
64
Increased
214
Reduced
993
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.97%
2 Financials 14.88%
3 Healthcare 12.5%
4 Industrials 10.33%
5 Consumer Discretionary 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDY icon
101
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$17M 0.19%
48,100
-42,500
-47% -$14.9M
ISRG icon
102
Intuitive Surgical
ISRG
$142B
$16.9M 0.19%
94,095
-1,374
-1% -$238K
ELV icon
103
Elevance Health
ELV
$84.7B
$16.7M 0.18%
69,617
-1,277
-2% -$350K
EFA icon
104
iShares MSCI EAFE ETF
EFA
$79.9B
$16.6M 0.18%
255,000
-71,000
-22% -$4.58M
WMB icon
105
Williams Companies
WMB
$88.4B
$16.5M 0.18%
684,552
-4,176
-0.6% -$105K
SPGI icon
106
S&P Global
SPGI
$120B
$16.4M 0.18%
67,027
-803
-1% -$201K
ZTS icon
107
Zoetis
ZTS
$31.1B
$16.2M 0.18%
129,961
-1,975
-1% -$238K
FISV
108
Fiserv Inc
FISV
$28B
$16.1M 0.18%
155,340
+47,169
+44% +$4.82M
NOC icon
109
Northrop Grumman
NOC
$81.8B
$16M 0.18%
42,822
-3,982
-9% -$1.41M
CCI icon
110
Crown Castle
CCI
$31.3B
$15.7M 0.17%
113,142
-1,452
-1% -$201K
CI icon
111
Cigna
CI
$72.4B
$15.6M 0.17%
102,761
-1,832
-2% -$298K
BSX icon
112
Boston Scientific
BSX
$74.2B
$15.4M 0.17%
379,079
-4,239
-1% -$180K
CSX icon
113
CSX Corp
CSX
$92.5B
$15M 0.17%
651,636
+15,981
+3% +$372K
AGN
114
DELISTED
Allergan plc
AGN
$15M 0.17%
89,270
+4,336
+5% +$706K
RTN
115
DELISTED
Raytheon Company
RTN
$14.9M 0.16%
75,789
-988
-1% -$183K
TGT icon
116
Target
TGT
$69.2B
$14.9M 0.16%
139,042
-2,177
-2% -$207K
PLD icon
117
Prologis
PLD
$133B
$14.6M 0.16%
171,753
-2,118
-1% -$175K
MS icon
118
Morgan Stanley
MS
$338B
$14.6M 0.16%
341,831
-10,573
-3% -$452K
DD icon
119
DuPont de Nemours
DD
$19.5B
$14.5M 0.16%
161,621
-2,809
-2% -$247K
DE icon
120
Deere & Co
DE
$167B
$14.5M 0.16%
85,689
-1,688
-2% -$270K
BLK icon
121
Blackrock
BLK
$178B
$14.2M 0.16%
31,970
-826
-3% -$368K
IWM icon
122
iShares Russell 2000 ETF
IWM
$81.8B
$14.1M 0.16%
93,400
-12,600
-12% -$1.92M
ICE icon
123
Intercontinental Exchange
ICE
$84.9B
$14.1M 0.15%
152,509
-2,914
-2% -$266K
MRSH
124
Marsh
MRSH
$91.3B
$13.8M 0.15%
137,786
-3,160
-2% -$316K
ECL icon
125
Ecolab
ECL
$79.8B
$13.5M 0.15%
68,128
-1,789
-3% -$359K

Similar funds

MetLife Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, MetLife Investment Management held 2,485 positions worth $9.09B, down 2.8% from $9.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management withdrew a net $296M in Q3 2019, closing 157 positions and reducing 993 holdings. Its most notable exit was Anadarko Petroleum, an estimated $9.77M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in T-Mobile US worth $6.78M.

  • MetLife Investment Management's largest Q3 2019 buy was T-Mobile US: 86,035 shares worth $6.78M.
  • MetLife Investment Management added most to Fidelity National Information Services in Q3 2019, an estimated $10.3M increase.
  • MetLife Investment Management's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $66.2M.
  • MetLife Investment Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $9.77M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.09B portfolio in Q3 2019.
  • MetLife Investment Management opened 64 new positions and closed 157 in Q3 2019.
  • MetLife Investment Management's portfolio value fell 2.8% quarter-over-quarter to $9.09B.

Based on MetLife Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.